1. Home
  2. AMGN
  3. AMGN News

Latest Amgen Inc. (AMGN) News on July 27, 2024

Amgen (AMGN) Stock Moves -0.39%: What You Should Know
AMGN

Zacks

a day ago

Amgen (AMGN) Stock Moves -0.39%: What You Should Know

Amgen Surges As Weight-Loss Trials Drive Excitement
AMGN

Investor's Business Daily

a day ago

Amgen Surges As Weight-Loss Trials Drive Excitement

What Lies in Store for Healthcare ETFs in Q2 Earnings?
AMGN

Zacks

2 days ago

What Lies in Store for Healthcare ETFs in Q2 Earnings?

Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
AMGN

Zacks

3 days ago

Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know

Investors in Amgen (NASDAQ:AMGN) have seen splendid returns of 122% over the past five years
AMGN

Simply Wall St.

4 days ago

Investors in Amgen (NASDAQ:AMGN) have seen splendid returns of 122% over the past five years

Nanotechnology in medicine: Who are the leading public companies?
AMGN

Medical Device Network

4 days ago

Nanotechnology in medicine: Who are the leading public companies?

Dow Jones Leader Amgen, Nvidia Stock, Coinbase In Or Near Buy Zones
AMGN

Investor's Business Daily

4 days ago

Dow Jones Leader Amgen, Nvidia Stock, Coinbase In Or Near Buy Zones

Beat the Market Like Zacks: Karooooo, UnitedHealth, Amgen in Focus
AMGN

Zacks

4 days ago

Beat the Market Like Zacks: Karooooo, UnitedHealth, Amgen in Focus

Pipeline Moves: Novo Nordisk progression prospects drop after candidate terminated
AMGN

Clinical Trials Arena

5 days ago

Pipeline Moves: Novo Nordisk progression prospects drop after candidate terminated

Amgen (AMGN) Ascends While Market Falls: Some Facts to Note
AMGN

Zacks

7 days ago

Amgen (AMGN) Ascends While Market Falls: Some Facts to Note

AMGN

MT Newswires

7 days ago

BMO Capital Adjusts Price Target on Amgen to $362 From $355, Outperform Rating Maintained

AMGN

MT Newswires

7 days ago

Jefferies Adjusts Price Target on Amgen to $380 From $375

Rivals Emerge to Ozempic and Zepbound—but With a Lag
AMGN

The Wall Street Journal

8 days ago

Rivals Emerge to Ozempic and Zepbound—but With a Lag

The Zacks Analyst Blog NVIDIA, Meta and Amgen Galaxy Gaming
AMGN

Zacks

8 days ago

The Zacks Analyst Blog NVIDIA, Meta and Amgen Galaxy Gaming

Amgen (AMGN) Dips More Than Broader Market: What You Should Know
AMGN

Zacks

8 days ago

Amgen (AMGN) Dips More Than Broader Market: What You Should Know

Q2 Earnings Season Scorecard, Economic Outlook and Analyst Reports for NVIDIA, Meta & Others
AMGN

Zacks

8 days ago

Q2 Earnings Season Scorecard, Economic Outlook and Analyst Reports for NVIDIA, Meta & Others

Insiders At Amgen Sold US$6.5m In Stock, Alluding To Potential Weakness
AMGN

Simply Wall St.

8 days ago

Insiders At Amgen Sold US$6.5m In Stock, Alluding To Potential Weakness

AMGN

Argus Research

10 days ago

Daily Spotlight: Biotech Sector Picks Up

Why Investors Need to Take Advantage of These 2 Medical Stocks Now
AMGN

Zacks

10 days ago

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Will Amgen (AMGN) Beat Estimates Again in Its Next Earnings Report?
AMGN

Zacks

11 days ago

Will Amgen (AMGN) Beat Estimates Again in Its Next Earnings Report?

Why Investors Need to Take Advantage of These 2 Medical Stocks Now
AMGN

Zacks

11 days ago

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Beyond Market Price: Uncovering Amgen Inc's Intrinsic Value
AMGN

GuruFocus.com

12 days ago

Beyond Market Price: Uncovering Amgen Inc's Intrinsic Value

What Is the Dividend Payout for Amgen Stock?
AMGN

Motley Fool

12 days ago

What Is the Dividend Payout for Amgen Stock?

3 Dividend Growth Stocks to Buy and Hold
AMGN

Motley Fool

13 days ago

3 Dividend Growth Stocks to Buy and Hold

Amgen Inc.'s (NASDAQ:AMGN) high institutional ownership speaks for itself as stock continues to impress, up 6.4% over last week
AMGN

Simply Wall St.

14 days ago

Amgen Inc.'s (NASDAQ:AMGN) high institutional ownership speaks for itself as stock continues to impress, up 6.4% over last week

Amgen (AMGN) Rises Higher Than Market: Key Facts
AMGN

Zacks

14 days ago

Amgen (AMGN) Rises Higher Than Market: Key Facts

Amgen’s Imdelltra BiTEs into SCLC treatment drought
AMGN

Clinical Trials Arena

14 days ago

Amgen’s Imdelltra BiTEs into SCLC treatment drought

AMGN

MT Newswires

14 days ago

UBS Raises Price Target on Amgen to $337 From $307, Maintains Neutral Rating

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
AMGN

Zacks

14 days ago

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It

AMGN

MT Newswires

15 days ago

Morgan Stanley Adjusts Price Target on Amgen to $303 From $310

Study Shows Lilly's (LLY) Obesity Drug More Effective Than NVO's
AMGN

Zacks

17 days ago

Study Shows Lilly's (LLY) Obesity Drug More Effective Than NVO's

Amgen Inc. (AMGN): Hedge Funds Are Bullish on This Blue Chip Dividend Stock Now
AMGN

Insider Monkey

17 days ago

Amgen Inc. (AMGN): Hedge Funds Are Bullish on This Blue Chip Dividend Stock Now

Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know
AMGN

Zacks

18 days ago

Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know

Beat the Market Like Zacks: Carvana, Adobe, Amgen in Focus
AMGN

Zacks

19 days ago

Beat the Market Like Zacks: Carvana, Adobe, Amgen in Focus

What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients
AMGN

Investor's Business Daily

22 days ago

What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients

EAN 2024: The role of B cells in shaping rituximab use in generalised MG
AMGN

Clinical Trials Arena

22 days ago

EAN 2024: The role of B cells in shaping rituximab use in generalised MG

NVO, LLY Slip After Study Links Obesity Drug Use to Vision Loss
AMGN

Zacks

22 days ago

NVO, LLY Slip After Study Links Obesity Drug Use to Vision Loss

Amgen Inc. (NASDAQ:AMGN) Shares Could Be 42% Below Their Intrinsic Value Estimate
AMGN

Simply Wall St.

23 days ago

Amgen Inc. (NASDAQ:AMGN) Shares Could Be 42% Below Their Intrinsic Value Estimate

Forget Eli Lilly: 3 Biotech Stocks to Buy Instead
AMGN

Motley Fool

23 days ago

Forget Eli Lilly: 3 Biotech Stocks to Buy Instead

Health Care Stocks With A Long History Of Dividend Growth And Solid Yields
AMGN

Benzinga

23 days ago

Health Care Stocks With A Long History Of Dividend Growth And Solid Yields

AMGN

MT Newswires

24 days ago

Alvotech Says Study on Proposed Biosimilar to Prolia, Xgeva Meets Primary Endpoints

AMGN

Investor's Business Daily

25 days ago

Dow Jones Falls Amid Powell Speech; Tesla Stock Surges On Deliveries

AMGN

GuruFocus.com

a month ago

Amgen Inc: An Exploration into Its Intrinsic Value

AMGN

Investor's Business Daily

a month ago

Dow Jones Rallies After Economic Data; Nvidia Gets Price Target Hike

10 clinical trials to watch in the second half of 2024
AMGN

BioPharma Dive

a month ago

10 clinical trials to watch in the second half of 2024

How Do These 3 Healthcare Dividend Stocks Deliver Reliable Income And Growth?
AMGN

Benzinga

a month ago

How Do These 3 Healthcare Dividend Stocks Deliver Reliable Income And Growth?

1 Dividend Growth Stock to Buy and Hold for 10 Years
AMGN

Motley Fool

a month ago

1 Dividend Growth Stock to Buy and Hold for 10 Years

AMGN

MT Newswires

a month ago

Argus Raises Amgen's Price Target to $340 From $300

AMGN

Argus Research

a month ago

Market Update: AMGN, LEN, MU, VFC, ALTM

AMGN

Argus Research

a month ago

Analyst Report: AMGEN Inc.

Can Amgen Stock Keep Trouncing the S&P 500?
AMGN

Motley Fool

a month ago

Can Amgen Stock Keep Trouncing the S&P 500?

Novo Nordisk, Eli Lilly still top 2 pharma stocks: Analyst
AMGN

Yahoo Finance Video

a month ago

Novo Nordisk, Eli Lilly still top 2 pharma stocks: Analyst

The Zacks Analyst Blog Highlights Chevron, Amgen, Philip Morris, Hurco and Perma-Pipe
AMGN

Zacks

a month ago

The Zacks Analyst Blog Highlights Chevron, Amgen, Philip Morris, Hurco and Perma-Pipe

Pharma M&A: The top high value deals in 2023
AMGN

Pharmaceutical Technology

a month ago

Pharma M&A: The top high value deals in 2023

Why Amgen (AMGN) Outpaced the Stock Market Today
AMGN

Zacks

a month ago

Why Amgen (AMGN) Outpaced the Stock Market Today

Top Stock Reports for Chevron, Amgen & Philip Morris
AMGN

Zacks

a month ago

Top Stock Reports for Chevron, Amgen & Philip Morris

BMS expands Krazati’s FDA label to include colorectal cancer
AMGN

Clinical Trials Arena

a month ago

BMS expands Krazati’s FDA label to include colorectal cancer

Biotech ETF (BBH) Hits New 52-Week High
AMGN

Zacks

a month ago

Biotech ETF (BBH) Hits New 52-Week High

BMS expands Krazati’s FDA label to include colorectal cancer
AMGN

Pharmaceutical Technology

a month ago

BMS expands Krazati’s FDA label to include colorectal cancer

The 30-stock secret: ‘Don’t fight Papa Dow’
AMGN

Yahoo Finance Video

a month ago

The 30-stock secret: ‘Don’t fight Papa Dow’

Amgen (AMGN) Gains As Market Dips: What You Should Know
AMGN

Zacks

a month ago

Amgen (AMGN) Gains As Market Dips: What You Should Know

Where Will Amgen Be in 5 Years?
AMGN

Motley Fool

a month ago

Where Will Amgen Be in 5 Years?

Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock
AMGN

Zacks

a month ago

Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock

Amgen's (AMGN) Blincyto Gets FDA Nod for Consolidation Treatment
AMGN

Zacks

a month ago

Amgen's (AMGN) Blincyto Gets FDA Nod for Consolidation Treatment

Unlocking Intrinsic Value: Analysis of Amgen Inc
AMGN

GuruFocus.com

a month ago

Unlocking Intrinsic Value: Analysis of Amgen Inc

FDA approves Amgen’s BLINCYTO for acute lymphoblastic leukaemia
AMGN

Pharmaceutical Technology

a month ago

FDA approves Amgen’s BLINCYTO for acute lymphoblastic leukaemia

AMGN

Morningstar Research

a month ago

Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover

AMGN

MT Newswires

a month ago

Amgen Says FDA Approves Blincyto to Treat Type of Blood Cancer

FDA APPROVES BLINCYTO® (BLINATUMOMAB) IN CD19-POSITIVE PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) IN THE CONSOLIDATION PHASE
AMGN

PR Newswire

a month ago

FDA APPROVES BLINCYTO® (BLINATUMOMAB) IN CD19-POSITIVE PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) IN THE CONSOLIDATION PHASE

AMGN

MT Newswires

a month ago

Update: RBC Raises Price Target on Amgen to $332 From $328, Maintains Outperform Rating

AMGN

MT Newswires

a month ago

RBC Raises Price Target on Amgen to $332 From $328, Maintains Outperform Rating

Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know
AMGN

Zacks

a month ago

Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know

Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks
AMGN

Investor's Business Daily

a month ago

Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks

Viridian (VRDN) Up 10% on Clinical Updates for Eye Disease Drug
AMGN

Zacks

a month ago

Viridian (VRDN) Up 10% on Clinical Updates for Eye Disease Drug

AMGEN TO PRESENT INNOVATIVE RHEUMATOLOGY RESEARCH AT EULAR 2024
AMGN

PR Newswire

a month ago

AMGEN TO PRESENT INNOVATIVE RHEUMATOLOGY RESEARCH AT EULAR 2024

Amgen (AMGN) Stock Fell After Some Concerns Regarding The Released Clinical Data
AMGN

Insider Monkey

a month ago

Amgen (AMGN) Stock Fell After Some Concerns Regarding The Released Clinical Data

Is Amgen Inc (NASDAQ:AMGN) the Top Dividend Stock to Buy in 2024?
AMGN

Insider Monkey

a month ago

Is Amgen Inc (NASDAQ:AMGN) the Top Dividend Stock to Buy in 2024?

Beat the Market Like Zacks: Goldman Sachs, Micron, Amgen in Focus
AMGN

Zacks

2 months ago

Beat the Market Like Zacks: Goldman Sachs, Micron, Amgen in Focus

Why Amgen (AMGN) Dipped More Than Broader Market Today
AMGN

Zacks

2 months ago

Why Amgen (AMGN) Dipped More Than Broader Market Today

Is Trending Stock Amgen Inc. (AMGN) a Buy Now?
AMGN

Zacks

2 months ago

Is Trending Stock Amgen Inc. (AMGN) a Buy Now?

Here’s Why Neogen Corporation (NEOG) Lowered Full-Year Revenue Guidance in Q1
AMGN

Insider Monkey

2 months ago

Here’s Why Neogen Corporation (NEOG) Lowered Full-Year Revenue Guidance in Q1

Rémy Cointreau: Information on the Total Number of Voting Rights and Shares Forming the Share Capital on the Date of Publication of the Meeting Notice of the Combined General Meeting of July 20, 2023
AMGN

Business Wire

2 months ago

Rémy Cointreau: Information on the Total Number of Voting Rights and Shares Forming the Share Capital on the Date of Publication of the Meeting Notice of the Combined General Meeting of July 20, 2023

Viking Therapeutics (VKTX) Shares Rose in Q1
AMGN

Insider Monkey

2 months ago

Viking Therapeutics (VKTX) Shares Rose in Q1

Global IPv6 Market Analysis and Forecast 2024-2034, Featuring Key Players Cisco Systems, D-Link, Hewlett Packard Enterprise Development and Verizon
AMGN

GlobeNewswire

2 months ago

Global IPv6 Market Analysis and Forecast 2024-2034, Featuring Key Players Cisco Systems, D-Link, Hewlett Packard Enterprise Development and Verizon

Qilu Pharmaceutical's Three Clinical Studies on Cancer Immunotherapy Presented at ASCO 2024
AMGN

PR Newswire

2 months ago

Qilu Pharmaceutical's Three Clinical Studies on Cancer Immunotherapy Presented at ASCO 2024

Airbus’s Deliveries in Next Months Will Be Decisive
AMGN

The Wall Street Journal

2 months ago

Airbus’s Deliveries in Next Months Will Be Decisive

Global Automated Passenger Counting and Information System Market Report 2024: Stereoscopic Vision Segment to Exhibit Highest CAGR Between 2024 and 2029
AMGN

GlobeNewswire

2 months ago

Global Automated Passenger Counting and Information System Market Report 2024: Stereoscopic Vision Segment to Exhibit Highest CAGR Between 2024 and 2029

Terminal Rate Expectations Seen Key Mover of 10-Year German Bunds
AMGN

The Wall Street Journal

2 months ago

Terminal Rate Expectations Seen Key Mover of 10-Year German Bunds

Amgen's (AMGN) Uplizna Meets Study Goal for Rare Disease
AMGN

Zacks

2 months ago

Amgen's (AMGN) Uplizna Meets Study Goal for Rare Disease

Why Is Intra-Cellular (ITCI) Up 1.2% Since Last Earnings Report?
AMGN

Zacks

2 months ago

Why Is Intra-Cellular (ITCI) Up 1.2% Since Last Earnings Report?

Amgen reports positive data from Phase III IgG4-RD treatment trial
AMGN

Clinical Trials Arena

2 months ago

Amgen reports positive data from Phase III IgG4-RD treatment trial

AMGEN TO PRESENT AT GOLDMAN SACHS 45TH ANNUAL GLOBAL HEALTHCARE CONFERENCE
AMGN

PR Newswire

2 months ago

AMGEN TO PRESENT AT GOLDMAN SACHS 45TH ANNUAL GLOBAL HEALTHCARE CONFERENCE

Amgen Seeks Expanded US Approval For Autoimmune Disease Drug Acquired Via $28B Horizon Deal
AMGN

Benzinga

2 months ago

Amgen Seeks Expanded US Approval For Autoimmune Disease Drug Acquired Via $28B Horizon Deal

AMGN

MT Newswires

2 months ago

Amgen Says Phase 3 Trial of Potential Autoimmune Disease Treatment Meets Endpoints

AMGEN ANNOUNCES POSITIVE RESULTS FOR PHASE 3 REGISTRATIONAL TRIAL EVALUATING UPLIZNA® (INEBILIZUMAB-CDON) FOR TREATMENT OF IMMUNOGLOBULIN G4-RELATED DISEASE (IgG4-RD)
AMGN

PR Newswire

2 months ago

AMGEN ANNOUNCES POSITIVE RESULTS FOR PHASE 3 REGISTRATIONAL TRIAL EVALUATING UPLIZNA® (INEBILIZUMAB-CDON) FOR TREATMENT OF IMMUNOGLOBULIN G4-RELATED DISEASE (IgG4-RD)

Dow Jones Biotech Amgen, Netflix, Robinhood, Spotify In Bullish Chart Setups
AMGN

Investor's Business Daily

2 months ago

Dow Jones Biotech Amgen, Netflix, Robinhood, Spotify In Bullish Chart Setups

AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCE
AMGN

PR Newswire

2 months ago

AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCE

The Gold Rush for Weight Loss Drugs Is Here. These 3 Latecomers Could Be Worth a Buy.
AMGN

Motley Fool

2 months ago

The Gold Rush for Weight Loss Drugs Is Here. These 3 Latecomers Could Be Worth a Buy.

Beyond Market Price: Uncovering Amgen Inc's Intrinsic Value
AMGN

GuruFocus.com

2 months ago

Beyond Market Price: Uncovering Amgen Inc's Intrinsic Value

Amgen Secures FDA Nod For Rare-Disease Treatment Biosimilar Based On AstraZeneca's Drug
AMGN

Benzinga

2 months ago

Amgen Secures FDA Nod For Rare-Disease Treatment Biosimilar Based On AstraZeneca's Drug

Share on Social Networks: